Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?
暂无分享,去创建一个
Kim Henriksen | M. Karsdal | E. Dam | P. Qvist | K. Henriksen | Per Qvist | Morten A. Karsdal | B. Sondergaard | Anne-Christine Bay-Jensen | Suzi Hoegh-Madsen | Erik Dam | Bodil Cecillie Sondergaard | Philippe Pastoureau | P. Pastoureau | A. Bay‐Jensen | Suzi Hoegh-Madsen
[1] Marie-Christine Chaboissier,et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. , 2002, Genes & development.
[2] D. Felson,et al. Osteoarthritis: is it a disease of cartilage or of bone? , 2004, Arthritis and rheumatism.
[3] H. Mankin,et al. Quantitative histologic analyses of articular cartilage and subchondral bone from osteoarthritic and normal human hips. , 1977, Acta orthopaedica Scandinavica.
[4] M. Karsdal,et al. Osteoclasts secrete non-bone derived signals that induce bone formation. , 2008, Biochemical and biophysical research communications.
[5] J. Edwards. Fibroblast biology: Development and differentiation of synovial fibroblasts in arthritis , 2000, Arthritis Research.
[6] P. Garnero,et al. Monitoring cartilage turnover , 2007, Current rheumatology reports.
[7] B. Swoboda,et al. Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes. , 2001, The American journal of pathology.
[8] M. Karsdal,et al. Mechanisms Involved in Skeletal Anabolic Therapies , 2006, Annals of the New York Academy of Sciences.
[9] M. Karsdal,et al. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. , 2005, The American journal of pathology.
[10] G N Duda,et al. Altered cartilage mechanics and histology in knee osteoarthritis: relation to clinical assessment (ICRS Grade). , 2005, Osteoarthritis and cartilage.
[11] C. Brew,et al. SOX9 transduction of a human chondrocytic cell line identifies novel genes regulated in primary human chondrocytes and in osteoarthritis , 2007, Arthritis research & therapy.
[12] S. Cremers,et al. Bone markers--new aspects. , 2008, Clinical laboratory.
[13] M. Karsdal,et al. Evaluation of Cartilage and Bone Degradation in a Murine Collagen Antibody‐induced Arthritis Model , 2008, Scandinavian journal of immunology.
[14] Hiroshi Kawaguchi,et al. Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models. , 2008, Molecules and cells.
[15] M. Karsdal,et al. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. , 2006, Osteoarthritis and cartilage.
[16] W. Stetler-Stevenson,et al. Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. , 1993, The Journal of clinical investigation.
[17] Yiping Chen,et al. Shox2 is required for chondrocyte proliferation and maturation in proximal limb skeleton. , 2007, Developmental biology.
[18] S. Morony,et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.
[19] Y. Henrotin,et al. Anabolic events in osteoarthritis. , 1999, Osteoarthritis and cartilage.
[20] L. Duong,et al. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. , 2006, Bone.
[21] M. Karsdal,et al. Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation. , 2007, Arthritis and rheumatism.
[22] Kozo Nakamura,et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. , 2006, Arthritis and rheumatism.
[23] K Henriksen,et al. Should subchondral bone turnover be targeted when treating osteoarthritis? , 2008, Osteoarthritis and cartilage.
[24] M. Karsdal,et al. In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist? , 2005, Assay and drug development technologies.
[25] F. Mallein-Gerin,et al. Alternative splicing of type II procollagen pre‐mRNA in chondrocytes is oppositely regulated by BMP‐2 and TGF‐β1 , 2003, FEBS letters.
[26] T. Aigner,et al. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. , 2003, Matrix biology : journal of the International Society for Matrix Biology.
[27] A. Hollander,et al. Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage , 1999, The Journal of pathology.
[28] J. Pelletier,et al. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts , 2006, Arthritis research & therapy.
[29] J. Pelletier,et al. Cathepsin B and cysteine protease inhibitors in human osteoarthritis , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[30] Claus Christiansen,et al. Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity? , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[31] J. Pelletier,et al. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. , 2006, Bone.
[32] T. Oegema,et al. Biochemical changes in articular cartilage after joint immobilization by casting or external fixation , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[33] L. Duong,et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. , 2004, Arthritis and rheumatism.
[34] C. Christiansen,et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM) , 2004, Menopause.
[35] J. Pelletier,et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. , 1989, The Journal of clinical investigation.
[36] H. Kronenberg,et al. Developmental regulation of the growth plate , 2003, Nature.
[37] J. V. van Meurs,et al. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis. , 1999, Arthritis and rheumatism.
[38] T. Aigner,et al. Roles of chondrocytes in the pathogenesis of osteoarthritis. , 2002, Current opinion in rheumatology.
[39] Claus Christiansen,et al. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity , 2008, Arthritis research & therapy.
[40] C. Christiansen,et al. Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation , 2008, BMC musculoskeletal disorders.
[41] M. Karsdal,et al. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. , 2005, Bone.
[42] M. Goldring. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. , 2006, Best practice & research. Clinical rheumatology.